ELDON BIOLOGICALS A/S: Financial statements 2024
CVR: 26747007
Source: annual report 2024, Danish Business Authority
01/07/2023 – 30/06/2024
ELDON BIOLOGICALS A/S (CVR 26747007) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 14,865,492 and a net result of DKK 6,673,643 compared with DKK 5,362,663 the year before. That is an increase of 20.8% compared with the year before. Equity in the 2024 report amounted to DKK 40,155,596. The solvency ratio was 86%. The company had 10 employees in the financial year.
- Gross Profit
- DKK 14,865,492
- Profit/Loss
- DKK 6,673,643
- Equity
- DKK 40,155,596
- Total Assets
- DKK 46,713,169
- Employees
- 10
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 14.9 mio. | 6.7 mio. | 40.2 mio. | 10 |
| 2023 | - | 12.3 mio. | 5.4 mio. | 34.5 mio. | 10 |
| 2022 | - | 16.4 mio. | 5 mio. | 29.6 mio. | 9 |
| 2021 | - | 19.5 mio. | 9.1 mio. | 25.1 mio. | 11 |
| 2020 | - | 14.3 mio. | 6.6 mio. | 16.5 mio. | 8 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout ELDON BIOLOGICALS A/S
ELDON BIOLOGICALS A/S is a Danish company of the type Aktieselskab based in Gentofte, founded in 2002. The company is registered under the industry Fremstilling af andre kemiske produkter i.a.n.. The management consists of Kasper Juul Hedegaard. The board consists of Michael Lützhøft Hansen (chair), Cara Beth Seiderman and Kasper Juul Hedegaard. The company is owned by MEDI-TRADE ApS and HOLDINGSELSKABET MLH ApS. The company has 9 employees (2018). In 2025, the company reported a gross profit of DKK 13,635,058 and a net result of DKK 3,900,353 compared with DKK 6,673,643 the year before. Equity in the 2025 report amounted to DKK 42,055,949.